Clinical Trial Update: Effect of Diclofenac Potassium Versus Prednisolone on Post-endodontic Pain and Pulpal IL-8 Expression [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing diclofenac potassium to prednisolone for post-endodontic pain and pulpal IL-8 expression in symptomatic irreversible pulpitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Symptomatic Irreversible Pulpitis

Drugs mentioned

• DICLOFENAC POTASSIUM (diclofenac potassium)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Cairo University | Conditions: Symptomatic Irreversible Pulpitis | Phase 4 | Status: UNKNOWN